The downregulated long noncoding RNA <em>DHRS4-AS1</em> is protumoral and associated with the prognosis of clear cell renal cell carcinoma

Abstract

Taken together, our findings identify the role of <i>DHRS4-AS1</i> as a tumor inhibitor in ccRCC for the first time, demonstrating that <i>DHRS4-AS1</i> is a potential prognostic biomarker that could potentially be applied in ccRCC therapy.